Fig. 1From: Validation in the ESPOIR cohort of vitamin K-dependent protein S (PROS) as a potential biomarker capable of predicting response to the methotrexate/etanercept combinationSchematic view of the study and populations of subgroups having received the different bDMARDsBack to article page